Authors:
Apfel, SC
Asbury, AK
Bril, V
Burns, TM
Campbell, JN
Chalk, CH
Dyck, PJ
Dyck, PJB
Feldman, EL
Fields, HL
Grant, IA
Griffin, JW
Klein, CJ
Lindblom, U
Litchy, WJ
Low, PA
Melanson, M
Mendell, JR
Merren, MD
O'Brien, PC
Rendell, M
Rizza, RA
Service, FJ
Thomas, PK
Walk, D
Wang, AK
Wessel, K
Windebank, AJ
Ziegler, D
Zochodne, DW
Citation: Sc. Apfel et al., Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials, J NEUR SCI, 189(1-2), 2001, pp. 3-5
Authors:
Nachamkin, I
Engberg, J
Gutacker, M
Meinersman, RJ
Li, CY
Arzate, P
Teeple, E
Fussin, V
Ho, TW
Asbury, AK
Griffin, JW
McKhann, GM
Piffaretti, JC
Citation: I. Nachamkin et al., Molecular population genetic analysis of Campylobacter jejuni HS : 19 associated with Guillain-Barre syndrome and gastroenteritis, J INFEC DIS, 184(2), 2001, pp. 221-226
Authors:
Ho, TW
Willison, HJ
Nachamkin, I
Li, CY
Veitch, J
Ung, H
Wang, GR
Liu, RC
Cornblath, DR
Asbury, AK
Griffin, JW
McKhann, GM
Citation: Tw. Ho et al., Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome., ANN NEUROL, 45(2), 1999, pp. 168-173
Authors:
Nachamkin, I
Ung, H
Moran, AP
Yoo, D
Prendergast, MM
Nicholson, MA
Sheikh, K
Ho, T
Asbury, AK
McKhann, GM
Griffin, JW
Citation: I. Nachamkin et al., Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States, J INFEC DIS, 179(5), 1999, pp. 1183-1189